Pre-market · Oct 6, 8:10 am ET · After hours $14.61 0.00%
Open$14.76
Prev close$15.37
Day range$14.58 – $14.79
Volume3,588
Market cap$1.36B
P/E (TTM)–
Dividend yield–
AAPG Stock News
Headlines matching Ascentage Pharma or the AAPG ticker, most recent first.
B. Riley Securities Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45Market news · 2 Sep 2026
Oppenheimer Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $45Market news · 21 Aug 2026
Analysts Offer Insights on NA Companies: Ascentage Pharma Group International Unsponsored ADR (AAPG), Fatpipe, Inc. (FATN) and Aptera Motors Corp. Class B (SEV)TipRanks · 21 Aug 2026
BTIG Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48Market news · 21 Aug 2026
Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy RatingMarket news · 21 Aug 2026
Oppenheimer Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45Market news · 15 Jun 2026
B. Riley Securities Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $45Market news · 10 Jun 2026
Piper Sandler Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $48Market news · 1 Jun 2026
Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $22.34Market news · 24 Apr 2026
Deutsche Bank Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $40Market news · 24 Apr 2026
J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Cuts Target Price to $46Market news · 16 Apr 2026
Truist Financial Maintains Ascentage Pharma(AAPG.US) With Buy Rating, Maintains Target Price $51Market news · 27 Mar 2026
BTIG Initiates Ascentage Pharma(AAPG.US) With Buy Rating, Announces Target Price $48Market news · 12 Mar 2026
J.P. Morgan Maintains Ascentage Pharma(AAPG.US) With Buy RatingMarket news · 22 Aug 2025
J.P. Morgan Sticks to Their Buy Rating for Ascentage Pharma Group International Unsponsored ADR (AAPG)TipRanks · 22 Aug 2025
Discussion
No comments yet — be the first to weigh in on AAPG.
No comments yet — be the first to weigh in on AAPG.